Lupin gets USFDA nod to market drug used to treat chronic hepatitis B

The company has received tentative approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application for Tenofovir Alafenamide tablets (25 mg), Lupin said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/K17SYh4
via IFTTT